Home Cart Sign in  
Chemical Structure| 97207-47-1 Chemical Structure| 97207-47-1

Structure of Meisoindigo
CAS No.: 97207-47-1

Chemical Structure| 97207-47-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Meisoindigo, a derivative of Indigo naturalis with anticancer activity, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML).

Synonyms: Natura-α; N-Methylisoindigotin; Methylisoindigotin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Meisoindigo

CAS No. :97207-47-1
Formula : C17H12N2O2
M.W : 276.29
SMILES Code : CN(C(/C1=C2C(NC3=CC=CC=C3/2)=O)=O)C4=C1C=CC=C4
Synonyms :
Natura-α; N-Methylisoindigotin; Methylisoindigotin
MDL No. :MFCD05988503
InChI Key :XZYXCQXTKOYHGK-UHFFFAOYSA-N
Pubchem ID :126274

Safety of Meisoindigo

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Panc1 5.45 μM 72 hours Inhibition of cell proliferation, IC50 of 5.45 μM Mol Oncol. 2016 Jun;10(6):806-24
HeLa cells 5 µM 30 minutes Inhibition of Stat3 activity Molecules. 2017 Sep 13;22(9):1546
HCT116 cells 9.09 µM 72 hours Anti-proliferative effects Molecules. 2017 Sep 13;22(9):1546
JoPaca-1 cells 20 µM 2 hours Inhibition of Stat3 activity Molecules. 2017 Sep 13;22(9):1546
K562 cells 10 μM 12 hours Mei significantly reduced PKMYT1 protein levels without affecting mRNA expression Adv Sci (Weinh). 2025 Jun;12(21):e2413676
Jopaca-1 20 μM 24 hours Reduction of CD133+ and ESA+/CD44+/CD24+ cell populations, decreased expression of CSC-associated genes, reduced cellular mobility and sphere formation Mol Oncol. 2016 Jun;10(6):806-24
BV2 cells 30 μM 6 hours To evaluate the effect of Meisoindigo on cell viability and its inhibition of the TLR4/NF-κB signaling pathway in the OGD/R model of BV2 cells. Results showed that Meisoindigo significantly improved cell viability and inhibited NLRP3 inflammasome activation. Front Cell Neurosci. 2019 Dec 16;13:553
HT-22 cells 50 μM 8 hours To evaluate the effect of Meisoindigo on cell viability and its inhibition of the TLR4/NF-κB signaling pathway in the OGD/R model of HT-22 cells. Results showed that Meisoindigo significantly improved cell viability and inhibited NLRP3 inflammasome activation. Front Cell Neurosci. 2019 Dec 16;13:553
SET2 cells 5, 10, 20μmol/L 12h To detect the effect of meisoindigo on the expression of apoptosis-related proteins in SET2 cells, results showed that the expression of anti-apoptotic proteins was down-regulated and the expression of pro-apoptotic proteins was up-regulated Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):29-34
SET2 cells 5, 10, 20μmol/L 12h To detect the effect of meisoindigo on the expression of JAK-STAT signaling pathway-related proteins in SET2 cells, results showed that the expression levels of related proteins were down-regulated with the increase of drug concentration Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):29-34
SET2 cells 5, 10, 20μmol/L 12h To detect the effect of meisoindigo on colony formation of SET2 cells, results showed that the colony formation rate decreased with the increase of drug concentration Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):29-34
SET2 cells 5, 10, 20μmol/L 24, 48, 72, 96h To detect the effect of meisoindigo on proliferation of SET2 cells, results showed that cell proliferation was inhibited Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):29-34
SET2 cells 5, 10μmol/L 24, 48, 72h To observe the effect of meisoindigo on apoptosis of SET2 cells, results showed that the apoptosis rate increased with the increase of drug concentration Zhonghua Xue Ye Xue Za Zhi. 2019 Jan 14;40(1):29-34

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice K562 ectopic xenograft tumor model Oral 150 mg/kg Once daily for 14 days Mei significantly inhibited wild-type K562 tumor growth but had no further inhibitory effect on PKMYT1-knockdown tumors Adv Sci (Weinh). 2025 Jun;12(21):e2413676
C57BL/6J wild-type mice Middle cerebral artery occlusion (MCAO) model Intraperitoneal injection 2, 4, 8, 12 mg/kg Administered before MCAO and 2 hours after reperfusion, lasting for 3 days To evaluate the neuroprotective effects of Meisoindigo in the MCAO model. Results showed that Meisoindigo significantly improved neurological scores, reduced infarct volume and cerebral edema, and inhibited NLRP3 inflammasome activation and M1 microglia/macrophage polarization. Front Cell Neurosci. 2019 Dec 16;13:553
Zebrafish Transgenic zebrafish model (Tg: zlyz-EGFP) Immersion 25 μM, 50 μM, 75 μM 6 hours To evaluate the inhibitory effect of Meisoindigo on zebrafish leukocyte chemotactic migration, results showed that Meisoindigo significantly inhibited leukocyte chemotactic migration in a dose-dependent manner. Pharm Biol. 2017 Dec;55(1):673-679

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.62mL

0.72mL

0.36mL

18.10mL

3.62mL

1.81mL

36.19mL

7.24mL

3.62mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories